Company Filing History:
1 out of 1,012 
1 out of 33 
Years Active: 2011
Title: Innovations of Thanh-Dung Nguyen in Anticarcinoma Antibodies
Introduction
Thanh-Dung Nguyen is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. His innovative work focuses on creating solutions that can aid in the diagnosis and treatment of carcinoma, especially lung carcinoma.
Latest Patents
Thanh-Dung Nguyen holds a patent for "Anticarcinoma antibodies and uses thereof." This patent describes a novel single domain antibody, AFAI, and its fragments, which exhibit specific affinity for binding to carcinoma cells. The applications of this antibody extend to both the diagnosis and treatment of carcinoma, showcasing its potential impact on cancer therapies.
Career Highlights
Throughout his career, Thanh-Dung Nguyen has worked with esteemed institutions such as the National Research Council of Canada and the Ottawa Hospital Research Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Colin Roger Mackenzie and Jianbing Zhang. Their collaborative efforts have further advanced the research and development of innovative solutions in the field of cancer treatment.
Conclusion
Thanh-Dung Nguyen's work in developing anticarcinoma antibodies represents a significant advancement in cancer research. His contributions have the potential to improve diagnostic and therapeutic strategies for carcinoma, particularly lung cancer.